Acute lymphoblastic leukaemia: open trials in Netherlands

21 open trials have a site in Netherlands. Registry data; only the trial team decides who can take part.

NCT07223021
A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia
Trial Treatment · Phase 3 · Memorial Sloan Kettering Cancer Center
Prinses Maxima Centrum voor Kinderoncologie B.V., Utrecht
Registry updated 2026-11-05
NCT06395103
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Prinses Maxima Centrum voor Kinderoncologie B.V., Utrecht
Registry updated 2026-10-30
NCT07570173
A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)
Trial Treatment · Phase 2/3 · Merck Sharp & Dohme LLC
Amsterdam UMC Stichting, Amsterdam · Sint Antonius Ziekenhuis Stichting, Nieuwegein · Radboud universitair medisch centrum Stichting, Nijmegen · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam · Prinses Maxima Centrum voor Kinderoncologie B.V., Utrecht
Registry updated 2026-10-30
NCT07476729
International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)
Trial Treatment · Phase 3 · Charite University, Berlin, Germany
Prinses Maxima Centrum voor Kinderoncologie B.V., Utrecht
Registry updated 2026-10-26
NCT05327894
Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Trial Treatment · Phase 3 · Princess Maxima Center for Pediatric Oncology
Princess Máxima Center for Pediatric Oncology, Utrecht
Registry updated 2026-10-19
NCT03934372
Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
Trial Treatment · Phase 1/2 · Incyte Biosciences International Sàrl
Princess Máxima Center for Pediatric Oncology, Utrecht
Registry updated 2026-10-09
NCT04065399
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Trial Treatment · Phase 1/2 · Syndax Pharmaceuticals
Prinses Maxima Centrum voor Kinderoncologie B.V., Utrecht
Registry updated 2026-10-09
2025-522019-40-00
Study of the safety and efficacy of asciminib in pediatric and young adult participants with r/r Ph+ or ABL-class Ph-like ALL
Trial Treatment · Phase 1/2 · Novartis Pharma AG
Prinses Maxima Centrum voor Kinderoncologie B.V., Utrecht
Registry updated 2026-10-06
NCT05748171
A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL
Trial Treatment · Phase 2 · Pfizer
Prinses Maxima Centrum voor Kinderoncologie B.V., Utrecht
Registry updated 2026-09-24
NCT01949129
Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
Trial Treatment · Phase 2/3 · St. Anna Kinderkrebsforschung
Prinses Maxima Centrum voor Kinderoncologie B.V., Utrecht
Registry updated 2026-09-04
NCT04307576
A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
Trial Treatment · Phase 3 · Mats Heyman
Prinses Maxima Centrum voor Kinderoncologie B.V., Utrecht · Universitair Medisch Centrum Utrecht, Utrecht
Registry updated 2026-08-12
2024-516570-30-00
A PRECISION MEDICINE RANDOMIZED TRIAL FOR PATIENTS WITH RELAPSED OR REFRACTORY T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA BASED ON A FUNCTIONAL APPROACH. ALL-TARGET TRIAL
Trial Treatment · Phase 2 · Centre Hospitalier De Versailles
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam · Universitair Medisch Centrum Utrecht, Utrecht
Registry updated 2026-06-08
2023-504694-20-00
Inotuzumab ozogamicin for Acute Lymphoblastic Leukemia
Trial Treatment · Phase 1/2 · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam · Prinses Maxima Centrum voor Kinderoncologie B.V., Utrecht
Registry updated 2026-06-04
2025-520982-39-00
Study on chemotherapy and experimental drugs in patients with Philadelphia Chromosome positive and ABL-class Philadelphia Chromosome-Like B-cell Acute Lymphoblastic Leukemia
Trial Treatment · Phase 3 · Universita Degli Studi Di Milano Bicocca
Princess Maxima Center Utrecht, Utrecht
Registry updated 2026-05-08
NCT03590171
International Study for Treatment of High Risk Childhood Relapsed ALL 2010
Trial Treatment · Phase 2 · Charite University, Berlin, Germany
Prinses Maxima Centrum voor Kinderoncologie B.V., Utrecht
Registry updated 2026-03-17
2024-515900-38-00
LUMC-BOB1-B7-TCR.1 in relapsed and refractory B-cell malignancies
Trial Treatment · Phase 1/2 · Leids Universitair Medisch Centrum (LUMC)
Leids Universitair Medisch Centrum (LUMC), Leiden
Registry updated 2026-02-09
NCT05658640
HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies
Trial Treatment · Phase 1/2 · Princess Maxima Center for Pediatric Oncology
Prinses Maxima Centrum voor Kinderoncologie B.V., Utrecht
Registry updated 2025-09-16
NCT05745714
HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
Trial Treatment · Phase 1/2 · Princess Maxima Center for Pediatric Oncology
Prinses Maxima Centrum voor Kinderoncologie B.V., Utrecht
Registry updated 2025-09-16
NCT05751044
HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
Trial Treatment · Phase 1/2 · Princess Maxima Center for Pediatric Oncology
Prinses Maxima Centrum voor Kinderoncologie B.V., Utrecht
Registry updated 2025-09-16
NCT06938009
Dutch Registry of Pediatric Cardiac Arrest
Research · Matthijs de Hoog
Amsterdam UMC, Amsterdam · UMCG, Groningen · LUMC, Leiden · MUMC+, Maastricht · Radboud UMC, Nijmegen · Erasmus MC, Rotterdam · UMCU, Utrecht
Registry updated 2025-04-22
NCT06166706
Current Practice of Ventilation Strategies in Children Undergoing General Anesthesia
Research · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Amsterdam University Medical Centers, Amsterdam
Registry updated 2025-04-09

All Acute lymphoblastic leukaemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error